UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006604 |
|---|---|
| Receipt number | R000007812 |
| Scientific Title | Phase I/II study to evaluate the efficacy and safety of the combination treatment of melpharan, dexamethasone and bortezomib for relapsed or refractory systemic AL amyloidosis. |
| Date of disclosure of the study information | 2011/10/24 |
| Last modified on | 2015/04/29 15:01:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/10/24 18:52:15 | ||
| 2 | Update | 2012/12/19 17:09:12 | Interventions/Control_1 Interventions/Control_1 Key exclusion criteria Key exclusion criteria |
|
| 3 | Update | 2013/05/29 17:55:16 | Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2013/05/29 17:58:19 | Institutions |
|
| 5 | Update | 2013/12/17 19:19:30 | Interventions/Control_1 Interventions/Control_1 |
|
| 6 | Update | 2013/12/17 19:26:56 | TEL Address |
|
| 7 | Update | 2014/05/20 10:34:24 | Organization Organization Organization Organization Institute Institute Organization1 Institutions |
|
| 8 | Update | 2015/04/29 15:01:05 | Recruitment status Date trial data considered complete |
